Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1282770/full, but it redirected us to https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1282770/full. The analysis below is for the second page.

Title[redir]:
Frontiers | Single-cell RNA sequencing analysis reveals the heterogeneity of IL-10 producing regulatory B cells in lupus-prone mice
Description:
IntroductionB cells can have both pathogenic and protective roles in autoimmune diseases, including systemic lupus erythematosus (SLE). Deficiencies in the n...

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Telecommunications

Content Management System {πŸ“}

What CMS is doi.org built with?


Doi.org uses TYPESETTER CMS.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,420 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We see no obvious way the site makes money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org might be earning cash quietly, but we haven't detected the monetization method.

Keywords {πŸ”}

cells, mice, cluster, cell, activedisease, predisease, bregs, disease, breg, gene, expression, clusters, figure, doi, text, google, scholar, crossref, full, analysis, subsets, abstract, regulatory, pubmed, lupus, singlecell, lupusprone, genes, active, producing, markers, autoimmunity, total, function, pbpc, compared, increased, autoimmune, populations, pcs, population, immunol, integrated, inflammatory, pbpcs, decreased, naΓ―ve, mrllpr, sets, trajectory,

Topics {βœ’οΈ}

cd19+il10+cd21+cd24hiigm+cd23+ cd19+il10+cd21+cd24hiigm+cd23 data availability statement lupus-prone mrl/lpr mice autoimmune-prone mrl/mp-faslpr single-cell rna sequencing active-disease mrl/lpr mice single-cell rna-seq apc conjugated anti-igh pre-disease plasmablast/plasma cell single-cell sequencing technology foxp3 fixation/permeabilization kit female mrl/lpr mice single-cell transcriptional analysis ethics statement single-cell transcriptional profiles integrated single-cell analysis nih/niams grants 1r01ar073240 single-cell trajectory analysis pb-pc pre-disease clusters italy cheong-wun kim cd138+il10+ pb-pcs induced monoclonal anti-mouse antibodies integrated single-cell clusters open-access article distributed t-bet dependent manner representing class-switched pcs post-gem rt-cleanup cell biotin-antibody cocktail pre-defined cell type phagocytic pb-pc subset pre-defined gene sets class-switched pcs indicative pro-inflammatory gene signatures identify disease stage-dependent pre-defined breg subset single-cell cluster markers pb-pc gene signature lupus-prone mice andrea lupus-prone mice prior pro-cell cycle genes cell marker-annotated clusters heightened pro-inflammatory environment active-disease mice exhibited typically retain poly-reactive/ transcriptionally defined alterations pro-inflammatory environment present disease stage-dependent differences rna-seq data single-cell datasets

Questions {❓}

  • Marginal zone B cells: From housekeeping function to autoimmunity?

Schema {πŸ—ΊοΈ}

ScholarlyArticle:
      context:https://schema.org
      headline:Single-cell RNA sequencing analysis reveals the heterogeneity of IL-10 producing regulatory B cells in lupus-prone mice
      author:
            type:Person
            name:Andrea R. Daamen
            affiliation:
               AMPEL BioSolutions LLC and the RILITE Research Institute, United States
            type:Person
            name:Razan M. Alajoleen
            affiliation:
               Department of Biomedical Sciences and Pathology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, United States
            type:Person
            name:Amrie C. Grammer
            affiliation:
               AMPEL BioSolutions LLC and the RILITE Research Institute, United States
            type:Person
            name:Xin M. Luo
            affiliation:
               Department of Biomedical Sciences and Pathology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, United States
            type:Person
            name:Peter E. Lipsky
            affiliation:
               AMPEL BioSolutions LLC and the RILITE Research Institute, United States
      datePublished:2023-12-14
      dateModified:2025-07-01
      publisher:
         type:Organization
         name:Frontiers
      isPartOf:
         type:PublicationIssue
         datePublished:2023
         isPartOf:
            type:PublicationVolume
            volumeNumber:14
            isPartOf:
               type:Periodical
               name:Frontiers in Immunology
      citation:
         https://doi.org/10.3389/fimmu.2023.1282770
      inLanguage:en
Person:
      name:Andrea R. Daamen
      affiliation:
         AMPEL BioSolutions LLC and the RILITE Research Institute, United States
      name:Razan M. Alajoleen
      affiliation:
         Department of Biomedical Sciences and Pathology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, United States
      name:Amrie C. Grammer
      affiliation:
         AMPEL BioSolutions LLC and the RILITE Research Institute, United States
      name:Xin M. Luo
      affiliation:
         Department of Biomedical Sciences and Pathology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, United States
      name:Peter E. Lipsky
      affiliation:
         AMPEL BioSolutions LLC and the RILITE Research Institute, United States
Organization:
      name:Frontiers
PublicationIssue:
      datePublished:2023
      isPartOf:
         type:PublicationVolume
         volumeNumber:14
         isPartOf:
            type:Periodical
            name:Frontiers in Immunology
PublicationVolume:
      volumeNumber:14
      isPartOf:
         type:Periodical
         name:Frontiers in Immunology
Periodical:
      name:Frontiers in Immunology

External Links {πŸ”—}(270)

Libraries {πŸ“š}

  • Vue.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Cloudflare
  • Crossref

5.51s.